Results 251 to 260 of about 3,645,817 (330)

What Do VLMs NOTICE? A Mechanistic Interpretability Pipeline for Gaussian-Noise-free Text-Image Corruption and Evaluation [PDF]

Michal Golovanevsky, William J. Rudman, Vedant Palit, Ritambhara Singh, Carsten Eickhoff   +4 more
openalex   +1 more source

Potential therapeutic targeting of BKCa channels in glioblastoma treatment

Molecular Oncology, EarlyView.
This review summarizes current insights into the role of BKCa and mitoBKCa channels in glioblastoma biology, their potential classification as oncochannels, and the emerging pharmacological strategies targeting these channels, emphasizing the translational challenges in developing BKCa‐directed therapies for glioblastoma treatment.
Kamila Maliszewska‐Olejniczak, Karolina Pytlak, Sandra Jaworowska, Bogusz Kulawiak, Piotr Bednarczyk   +4 more
wiley   +1 more source

Notice

Biolinguistics, 2012
The Editors
doaj   +1 more source

Retraction notice to "Polluting industries: Does green industrial policy encourage green innovation? Chinese perspective evidence" [Heliyon 10 (2024) e36634]. [PDF]

Heliyon
Yang H, Umair M.
europepmc   +1 more source

Notice of Retraction: Trimetallic Catalysts for Continuous Catalytic Oxidation of Aqueous Phenol

, 2011
Wenzhao Chen, Guangming Li, Hua Wang, Huikang Hu   +3 more
openalex   +2 more sources

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

Molecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute, Júlia Huguet‐Pradell, Jordi Abril‐Fornaguera, Albert Gris‐Oliver, Alex Rialdi, Elisa Fernández‐Martínez, Carla Montironi, Vanessa Del Pozo, Peter Houghton, Laura Zanatto, Agavni Mesropian, Ieva Keraite, Swan Thung, Carolina Armengol, Pau Sancho‐Bru, Ernesto Guccione, Roser Pinyol, Josep M. Llovet   +17 more
wiley   +1 more source

Notice

Biolinguistics, 2008
The Editors
doaj   +1 more source

Retraction notice to "Computational analysis of anti-cancer drug hydroxyurea adsorption on nanocages of gold, silver and copper: SERS and DFT assessment" [Heliyon 10 (2024) e24475]. [PDF]

Heliyon
Kumaran S, Vetrivelan V, Muthu S, Al-Saadi AA.   +3 more
europepmc   +1 more source

Les notices d'Aldébaran

, 2012
Jean-Christophe Peyssard, Véronique Ginouvès, Anaïs Salamon   +2 more
openalex   +1 more source

Exploiting metabolic adaptations to overcome dabrafenib treatment resistance in melanoma cells

Molecular Oncology, EarlyView.
We show that dabrafenib‐resistant melanoma cells undergo mitochondrial remodeling, leading to elevated respiration and ROS production balanced by stronger antioxidant defenses. This altered redox state promotes survival despite mitochondrial damage but renders resistant cells highly vulnerable to ROS‐inducing compounds such as PEITC, highlighting redox
Silvia Eller, Susanne Ebner, Carmen Haselrieder, Julia K. Günther, Astrid Drasche, Sophie Strich, Chiara Volani, Andrea Medici, Aleksandar Nikolajevic, Alex Deltedesco, Johannes E. Sigmund, Michael J. Blumer, Martin Hermann, Johanna Vanacker, Gerald Brandacher, Eduard Stefan, Omar Torres‐Quesada, Jakob Troppmair   +17 more
wiley   +1 more source